Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
2021 · Nature · 668 citations
https://doi.org/10.1038/s41586-021-04266-9
S
Seiya Yamayoshi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
9.4K
Citations
43
h-index
101
i10-index
Seiya Yamayoshi is an academic researcher from National Center for Global Health and Medicine. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies & Respiratory viral infections research. The author has an h-index of 43, co-authored 148 publications.
ORCID: 0000-0001-7768-5157Papers by this author
worksA human isolate of bovine H5N1 is transmissible and lethal in animal models
2024 · Nature · 119 citations
https://doi.org/10.1038/s41586-024-08254-7
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
2022 · Nature · 106 citations
https://doi.org/10.1038/s41586-022-05482-7
CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus
2022 · iScience · 62 citations
https://doi.org/10.1016/j.isci.2022.103830
A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
2022 · Nature Communications · 57 citations
https://doi.org/10.1038/s41467-022-34521-0
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
2023 · EBioMedicine · 47 citations
https://doi.org/10.1016/j.ebiom.2023.104561
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat